2019
Introduction to the Neuropathic Foot: Limb Salvage Pathway and Algorithm
Petrova N, Sumpio B, Edmonds M. Introduction to the Neuropathic Foot: Limb Salvage Pathway and Algorithm. 2019, 25-29. DOI: 10.1007/978-3-319-17918-6_2.Peer-Reviewed Original ResearchNeuropathic footImpact of neuropathySoft tissue advancementSplit skin graftSoft tissue coverageLocal rotational flapFree tissue transferPlatelet-rich plasmaAdvanced wound therapiesMatrix metalloproteinase inhibitorsLimb salvageCell-based therapiesSkin graftsTissue coverageWound therapyRotational flapTissue transferRecombinant growth factorsRich plasmaGrowth factorMetalloproteinase inhibitorsTissue advancementSenescent cellsTherapyAcellular matrixStrategies for Leg Amputation in Patients with Charcot’s Arthropathy
Chen J, Sumpio B. Strategies for Leg Amputation in Patients with Charcot’s Arthropathy. 2019, 195-203. DOI: 10.1007/978-3-319-17918-6_16.Peer-Reviewed Original ResearchNegative pressure wound therapyCharcot arthropathyMajor lower extremity amputationChallenging disease processLower extremity amputationPressure wound therapyProper wound healingExtremity amputationLeg amputationWound healing processWound therapyDisease processAmputationArthropathyWound healingPatientsLimbSpecial considerationEdemaHypervascularityPathophysiologyTherapyUse of Closed-Incision Negative-Pressure Therapy: Cardiothoracic and Vascular Surgery.
Wu RT, Sumpio BJ, Miller S, Sumpio BE. Use of Closed-Incision Negative-Pressure Therapy: Cardiothoracic and Vascular Surgery. Plastic & Reconstructive Surgery 2019, 143: 31s-35s. PMID: 30586101, DOI: 10.1097/prs.0000000000005310.Peer-Reviewed Original ResearchConceptsNegative pressure therapyVascular surgeryClosed incision negative pressure therapyIncision negative pressure therapySurgical site infectionMedian sternotomy infectionsGroin woundsSerious sequelaeSite infectionSternotomy infectionsGauze dressingsTraditional gauze dressingsSurgeryTherapyCardiothoracicInfectionRecent enthusiasmComplicationsSequelae
2016
Thrombus Resolution as Guide to Anticoagulation Therapy for Provoked Deep Vein Thrombosis: TRUDVT Pilot Study
Brownson K, Satoskar S, Reynolds J, Sumpio B, Sarac T, Scoutt L, Lee A. Thrombus Resolution as Guide to Anticoagulation Therapy for Provoked Deep Vein Thrombosis: TRUDVT Pilot Study. Journal Of Vascular Surgery Venous And Lymphatic Disorders 2016, 4: 149. DOI: 10.1016/j.jvsv.2015.10.040.Peer-Reviewed Original Research
2014
New advances in limb salvage.
Chin JA, Sumpio BE. New advances in limb salvage. Surgical Technology Online 2014, 25: 212-6. PMID: 25433346.Peer-Reviewed Original ResearchCritical limb ischemiaLimb salvageDistal vein patchType of therapyDrug-eluting stentsQuality of lifeEndovascular therapyLimb ischemiaPatient mortalityVein patchPoor outcomeEndovascular interventionTreatment optionsMorbid diseaseVascular surgerySurgical techniqueLimb lossHealthcare costsEpidemiologic problemNew advancesTherapySalvageInterventionFurther research
2013
Omental Vein Catheter Thrombolysis for Acute Porto-Mesenteric Vein Thrombosis
Fonseca AL, Cleary MA, Cholewczynski W, Sumpio BE, Atweh NA. Omental Vein Catheter Thrombolysis for Acute Porto-Mesenteric Vein Thrombosis. Annals Of Vascular Surgery 2013, 27: 497.e1-497.e4. PMID: 23566871, DOI: 10.1016/j.avsg.2012.09.009.Peer-Reviewed Original Research
2007
Changing Patterns in the Use of Inferior Vena Cava Filters: Review of a Single Center Experience
Aziz F, Spate K, Wong J, Aruny J, Sumpio B. Changing Patterns in the Use of Inferior Vena Cava Filters: Review of a Single Center Experience. Journal Of The American College Of Surgeons 2007, 205: 564-569. PMID: 17903730, DOI: 10.1016/j.jamcollsurg.2007.05.026.Peer-Reviewed Original ResearchConceptsRetrievable IVC filtersIVC filtersVenous accessFilter placementInferior vena cava filterDuration of therapySingle-center experienceGroup of patientsSuitability of patientsProphylactic filter placementVena cava filtersPatient demographicsPulmonary embolismCenter experienceComplication ratePatient chartsCava filtersJugular veinLevel IPatientsPlacementIndicationsYears 1999EmbolismTherapy
2006
The management of deep sternal wound infections using vacuum assisted closure™ (V.A.C.®) therapy
Fleck T, Gustafsson R, Harding K, Ingemansson R, Lirtzman MD, Meites HL, Moidl R, Price P, Ritchie A, Salazar J, Sjögren J, Song DH, Sumpio BE, Toursarkissian B, Waldenberger F, Wetzel‐Roth W. The management of deep sternal wound infections using vacuum assisted closure™ (V.A.C.®) therapy. International Wound Journal 2006, 3: 273-280. PMID: 17199763, PMCID: PMC7951489, DOI: 10.1111/j.1742-481x.2006.00273.x.Peer-Reviewed Original ResearchConceptsDeep sternal wound infectionSternal wound infectionWound infectionV.A.C. therapyThorough wound irrigationPrinciples of treatmentVacuum-assisted closureTreatment of infectionsSurgical debridementClinical guidelinesEarly recognitionWound irrigationAssisted closureCurrent evidenceSurgical supervisionTherapyInfectionAdequate experienceInternational expertsTreatmentInternational groupDebridementGroupGroup discussionsClinicians
2000
Tissue Plasminogen Activator: Biological and Physiological Relevance for Vascular Surgeons
Chang R, Kamal K, Sumpio B. Tissue Plasminogen Activator: Biological and Physiological Relevance for Vascular Surgeons. 2000, 1315-1323. DOI: 10.1007/978-1-4612-1190-7_103.Peer-Reviewed Original ResearchTissue-type plasminogen activatorThrombolytic therapyDeep venous thrombosisOcclusive vascular diseaseEfficacy of treatmentCerebrovascular accidentPulmonary embolismVenous thrombosisClinical outcomesMyocardial infarctionVascular diseaseVascular surgeonsHuman trialsEffective treatmentThrombolytic agentsPlasminogen activatorTherapyPhysiological relevanceTreatmentEndogenous propertiesEmbolismInfarctionThrombosisPatientsAgents
1984
Urinary excretion of interferon, albumin, and beta 2-microglobulin during interferon treatment.
Sumpio BE, Ernstoff MS, Kirkwood JM. Urinary excretion of interferon, albumin, and beta 2-microglobulin during interferon treatment. Cancer Research 1984, 44: 3599-603. PMID: 6378373.Peer-Reviewed Original ResearchConceptsInterferon therapyUrinary excretionInterferon activityPhase I trialSerum interferon activityUrinary betaInterferon administrationI trialSignificant nephrotoxicityTubular lesionsUrinary levelsInterferon treatmentHighest dosing levelDosing levelsTherapyInterferonExcretionTreatmentLow affinityAlbuminBetaNephrotoxicityPatientsLesionsPharmacokinetics